Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts

Journal of Virology

Volumn 74, Issue 2, 2000, Pages 992-996

  Hansen, Jonathan ^a,b   Qing, Keyun ^a,b   Kwon, Hyung Joo ^a,b   Mah, Cathryn ^c   Srivastava, Arun ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ARTICLE; DNA SYNTHESIS; GENE THERAPY; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

3T3 CELLS; ANIMALS; BIOLOGICAL TRANSPORT; CELL TRANSFORMATION, VIRAL; DEPENDOVIRUS; ENZYME INHIBITORS; GENES, REPORTER; GENETIC VECTORS; HELA CELLS; HUMANS; LAC OPERON; MICE; TYRPHOSTINS;

EID: 0033987571     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.2.992-996.2000     Document Type: Article

References (41)

1. Alexander, I. E., D. W. Russell, A. M. Spence, and A. D. Miller. 1996. Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by recombinant adeno-associated virus vectors. Hum. Gene Ther. 7:841-850.
2. Bartlett, J. S., R. J. Samulski, and T. J. McCown. 1998. Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum. Gene Ther. 9:1181-1186.
3. Berns, K. I., and R. A. Bohenzky. 1987. Adeno-associated viruses: an update. Adv. Virus Res. 32:243-307.
4. Berns, K. I., and C. Giraud. 1996. Biology of adeno-associated virus. Curr. Top. Microbiol. lmmunol. 218:1-23.
5. Carter, B. J., and T. R. Flotte. 1996. Development of adeno-associated virus vectors for gene therapy of cystic fibrosis. Curr. Top. Microbiol. Immunol. 218:119-144.
6. Chatterjee, S., D. Lu, G. Podsakoff, and K. K. Wong, Jr. 1995. Strategies for efficient gene transfer into hematopoietic cells: the use of adeno-associated virus vectors in gene therapy. Ann. N. Y. Acad. Sci. 770:79-90.
7. Ferrari, F. K., T. Samulski, T. Shenk, and R. J. Samulski. 1996. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:3227-3234.
8. Fisher, K. J., G.-P. Gao, M. D. Weitzman, R. DeMatteo, J. F. Burda, and J. M. Wilson. 1996. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 79:520-532.
9. Herzog, R. W., E. Y. Yang, L. B. Couto, J. N. Hagstrom, D. Elwell, P. A. Fields, M. Burton, D. A. Bellinger, M. S. Read, K. M. Brinkhous, G. M. Podsakoff, T. C. Nichols, G. J. Kurtzman, and K. A. High. 1999. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat. Med. 5:56-63.
10. Kaplitt, M. G., P. Leone, R. J. Samulski, X. Xiao, D. W. Pfaff, K. L. O'Malley, and M. J. During. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:148-153.
11. Kasamatsu, H., and A. Nakanishi. 1998. How do animal viruses get to the nucleus? Annu. Rev. Microbiol. 52:627-686.
12. Kessler, P. D., G. M. Podsakoff, X. Chen, S. A. McQuiston, P. C. Colosi, L. A. Matelis, G. J. Kurtzman, and B. J. Byrne. 1996. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93:14082-14087.
13. Koeberl, D. D., I. E. Alexander, C. L. Halbert, D. W. Russell, and A. D. Miller. 1997. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 94:1426-1431.
14. Kotin, R. M., J. C. Menninger, D. C. Ward, and K. I. Berns. 1991. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10:831-834.
15. Kotin, R. M., M. Siniscalco, R. J. Samulski, X. D. Zhu, L. A. Hunter, C. A. Laughlin, S. K. McLaughlin, N. Muzyczka, M. Rocchi, and K. I. Berns. 1990. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 87:2211-2215.
16. Mah, C., K. Y. Qing, B. Khuntirat, S. Ponnazhagan, X.-S. Wang, D. M. Kube, M, C. Yoder, and A. Srivastava. 1998. Adeno-associated virus 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression. J, Virol. 72:9835-9843.
17. McCown, T. J., X. Xiao, J. Li, G. R. Breese, and R. J. Samulski. 1996. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713:99-107.
18. Muzyczka, N. 1992. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158:97-129.
19. + hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation. J. Virol. 71:8262-8267.
20. Ponnazhagan, S., P. Mukherjee, M. C. Yoder, X.-S. Wang, S. Z. Zhou, J. Kaplan, S. Wadsworth, and A. Srivastava. 1997. Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene 190:203-210.
21. Ponnazhagan, S., X.-S. Wang, M. J. Woody, F. Luo, L. Y. Rang, M. L. Nallari, N. C. Munshi, S. Z. Zhou, and A. Srivastava. 1996. Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection. J. Gen. Virol. 77:1111-1122.
22. Ponnazhagan, S., M. C. Yoder, and A. Srivastava. 1997. Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo. J. Virol. 71:3098-3104.
23. Qing, K. Y., B. Khuntirat, C. Mah, D. M. Kube, X.-S. Wang, S. Ponnazhagan, S. Z. Zhou, V. J. Dwarki, M. C. Yoder, and A. Srivastava. 1998. Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J. Viral. 72:1593-1599.
24. Qing, K. Y., C. Mah, J. Hansen, S. Z. Zhou, V. J. Dwarki, and A. Srivastava. 1999. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5:71-77.
25. Qing, K. Y, X.-S. Wang, D. M. Kube, S. Ponnazhagan, A. Bajpai, and A. Srivastava. 1997. Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc. Katl. Acad. Sci. USA 94:10879-10884.
26. Rivera, V. M., X. Ye, N. L. Courage, J. Sachar, F. Cerasoli, J. M. Wilson, and M. Gilman. 1999. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proc. Natl. Acad. Sci. USA 96:8657-8662.
27. Samulski. R. J., X. Zhu, X. Xiao, J. D. Brook, D. E. Houseman, N. Epstein, and L. A. Hunter. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10:3941-3950.
28. Snyder, R. O., C. Miao, L. Meuse, J. Tubb, B. A. Donahue, H.-F. Lin, D. W. Stafford, S. Patel, A. R. Thompson, T. C. Nichols, M. S. Read, D. A. Bellinger, K. M. Brinkhous, and M. A. Kay. 1999. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat. Med. 5:64-70.
29. Sodeik, B., M. Ebersold, and A. Helenius. 1997. Dynein mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. 136:1007-1021.
30. Song, S., M. Morgan, T. Ellis, A. Poirier, K. Chesnut, J. Wang, M. Brantley, N. Muzyczka, B. J. Byrne, M. Atkinson, and T. R. Flotte. 1998. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 95:14384-14388.
31. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
32. Sperinde, V., and M. A. Nugent. 1998. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells. Biochemistry 37:13153-13164.
33. Srivastava, A. 1998. Delivery systems for gene therapy: adeno-associated virus 2, p. 257-288. In P. J. Quesenberry, G. S. Stein, B. G. Forget, and S. M. Weissman (ed.), Stem cell biology and gene therapy. Wiley-Liss. Inc., New York, N. Y.
34. Srivastava, A. 1999. Parvoviral vectors for human hematopoietic gene therapy, p. 89-122. In L. J. Fairbairn and N. Testa (ed.), Blood cell biochemistry, vol. 8. Hematopoiesis and gene therapy. Kluwer Academic/Plenum Publishers. New York. N. Y.
35. Srivastava, A., X.-S. Wang, S. Ponnazhagan, S. Z. Zhou, and M. C. Yoder. 1996. Adeno-associated virus 2-mediated transduction and erythroid lineage-specific expression in human hematopoietic progenitor cells. Curr. Top. Microbiol. Immunol. 218:93-117.
36. Summerford, C., J. S. Bartlett, and R. J. Samulski. 1999. αVβS integrin: a co-receptor for adeno-associated virus 2 infection. Nat. Med. 5:78-82.
37. Summerford, C., and R. J. Samulski. 1998. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1438-1445.
38. Suomalainen, M., M. Y. Nakano, S. Keller, K. Boucke, R. P. Stidwell, and U. F. Greber. 1999. Microtubule-dependent plus-and minus end-directed motilities are competing processes for nuclear targeting of adenovirus. J. Cell Biol. 144:657-672.
39. Tan, M. Q., K. Y. Qing, M. C. Yoder, and A. Srivastava. Adeno-associated virus 2-mediated transduction of primary murine hematopoietic progenitor cell in vitro and in vivo. Blood, in press.
40. Walsh, C. E., J. M. Liu, J. L. Miller, A. W. Nienhuis, and R. J. Samulski. 1993. Gene therapy for human hemoglobinopathies. Proc. Soc. Exp. Biol. Med. 204:289-300.
41. Xiao, X., L. Li, and R. J. Samulski. 1996. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:8098-8108.